NPs Top US Jobs List Again - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

  • By

  • Kerri Miller

  • January 15, 2026

  • 3 min

Share

Objective:

To highlight the recognition of nurse practitioners (NPs) as the top job in the U.S. for the third consecutive year, emphasizing their critical role in healthcare delivery.

Approach:
    Key Findings:
    • Nurse practitioners ranked as the Best Job, Best Health Care Job, and Best STEM Job for 2026.
    • The ranking reflects NPs' advanced clinical expertise and growing demand.
    • A Gallup Poll shows sustained public trust in nurses, including NPs, as the most honest and ethical profession.
    • More than 461,000 licensed NPs practice nationwide, delivering patient-centered care.
    Interpretation:

    The recognition of NPs underscores their critical role in healthcare delivery, the trust they have built with patients, and its positive impact on patient outcomes.

    Limitations:
    • There may still be misconceptions about the NP role among some patients, particularly regarding their training and capabilities.
    Conclusion:

    The continued top ranking of nurse practitioners reinforces their importance in healthcare and highlights the need for ongoing education to address knowledge gaps regarding their capabilities.

    Sources:

Original Source(s)

NPs Top US Jobs List Again

  • by Kerri Miller

  • January 15, 2026

Related Content

Serostatus May Modify RA Activity–CV Link

Combined rheumatoid factor and anticitrullinated protein antibody status appeared to modify the association between baseline rheumatoid arthritis disease activity and subsequent cardiovascular events in an international observational cohort.

Can LAI-CAB Sustain Long-Term PrEP Use?

A national claims analysis found modest uptake and declining persistence over 2 years despite increasing use of injectable HIV pre-exposure prophylaxis.

Oral Shigella Vaccine Hits 89% Efficacy in Challenge Trial

An investigational oral Shigella sonnei vaccine showed robust protection against shigellosis in a phase 2 controlled human infection trial.